The event will include presentations from Tourmaline's leadership team and Dr. Marc Bonaca, a cardiologist and vascular med Tourmaline Bio, Inc. ( (TRML) ) has released its Q3 earnings.
TOURMALINE BIO ($TRML) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.86 per share, beating estimates of -$0.89 by $0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback